BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31122805)

  • 1. Astrocytes: Emerging Therapeutic Targets in Neurological Disorders.
    Valori CF; Guidotti G; Brambilla L; Rossi D
    Trends Mol Med; 2019 Sep; 25(9):750-759. PubMed ID: 31122805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Functions of Reactive Astrocytes Following Central Nervous System Insult.
    Linnerbauer M; Rothhammer V
    Front Immunol; 2020; 11():573256. PubMed ID: 33117368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing.
    Chen Y; Qin C; Huang J; Tang X; Liu C; Huang K; Xu J; Guo G; Tong A; Zhou L
    Cell Prolif; 2020 Mar; 53(3):e12781. PubMed ID: 32035016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes.
    Suga M; Kondo T; Inoue H
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of monocytes to nervous system disorders.
    Garré JM; Yang G
    J Mol Med (Berl); 2018 Sep; 96(9):873-883. PubMed ID: 30030568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders.
    Valori CF; Possenti A; Brambilla L; Rossi D
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and therapeutic value of astrocytes in neurological diseases.
    Lee HG; Wheeler MA; Quintana FJ
    Nat Rev Drug Discov; 2022 May; 21(5):339-358. PubMed ID: 35173313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders.
    Miyazaki I
    Curr Pharm Des; 2017; 23(33):4933-4935. PubMed ID: 29022514
    [No Abstract]   [Full Text] [Related]  

  • 9. Functions of flavonoids in the central nervous system: Astrocytes as targets for natural compounds.
    Matias I; Buosi AS; Gomes FC
    Neurochem Int; 2016 May; 95():85-91. PubMed ID: 26845377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation.
    Jha MK; Jo M; Kim JH; Suk K
    Neuroscientist; 2019 Jun; 25(3):227-240. PubMed ID: 29931997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.
    Riikonen R
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28954393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte dysfunction in neurological disorders: a molecular perspective.
    Seifert G; Schilling K; Steinhäuser C
    Nat Rev Neurosci; 2006 Mar; 7(3):194-206. PubMed ID: 16495941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases.
    Finsterwald C; Magistretti PJ; Lengacher S
    Curr Pharm Des; 2015; 21(25):3570-81. PubMed ID: 26166612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New roles for astrocytes (stars at last).
    Ransom B; Behar T; Nedergaard M
    Trends Neurosci; 2003 Oct; 26(10):520-2. PubMed ID: 14522143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Calcium Signals in Reactive Astrocytes: A Key Process in Neurological Disorders.
    Shigetomi E; Saito K; Sano F; Koizumi S
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
    Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
    J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats.
    Aguado F; Ballabriga J; Pozas E; Ferrer I
    Acta Neuropathol; 1998 Nov; 96(5):495-501. PubMed ID: 9829813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
    Avila-Muñoz E; Arias C
    Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway.
    Skaper SD; Facci L; Leon A
    J Neurochem; 1995 Jan; 64(1):266-76. PubMed ID: 7798922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-controlled astrocytes promote human mesenchymal stem cells toward neuronal differentiation and improve the neurological deficit in stroke rats.
    Tu J; Yang F; Wan J; Liu Y; Zhang J; Wu B; Liu Y; Zeng S; Wang L
    Glia; 2014 Jan; 62(1):106-21. PubMed ID: 24272706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.